During the last decade the number of reported outbreaks caused by highly pathogenic avian influenza (HPAI) in domestic poultry has drastically increased. At the same time, low pathogenic avian influenza (LPAI) strains, such as H9N2 in many parts of the Middle East and Asia and H6N2 in live bird markets in California, have become endemic. Each AI outbreak brings the concomitant possibility of poultry-to-human transmission. Indeed, human illness and death have resulted from such occasional transmissions with highly pathogenic avian H7N7 and H5N1 viruses while avian H9N2 viruses have been isolated from individuals with mild influenza. The transmission of avian influenza directly from poultry to humans has brought a sense of urgency in terms of understanding the mechanisms that lead to interspecies transmission of influenza. Domestic poultry species have been previously overlooked as potential intermediate hosts in the generation of influenza viruses with the capacity to infect humans. In this review, we will discuss molecular and epidemiological aspects that have led to the recurrent emergence of avian influenza strains with pandemic potential, with a particular emphasis on the current Asian H5N1 viruses.

1.
Acland HM, Silverman Bachin LA, Eckroade RJ: Lesions in broiler and layer chickens in an outbreak of highly pathogenic avian influenza virus infection. Vet Pathol 21:564–569 (1984).
2.
Alexander DJ: Ecological aspects of influenza A viruses in animals and their relationship to human influenza: a review. J R Soc Med 75:799–811 (1982).
3.
Alexander DJ: A review of avian influenza in different bird species. Vet Microbiol 74:3–13 (2000).
4.
Aragon T, de la Luna S, Novoa I, Carrasco L, Ortin J, Nieto A: Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol 20:6259–6268 (2000).
5.
Banks J, Speidel ES, Moore E, Plowright L, Piccirillo A, et al: Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy. Arch Virol 146:963–973 (2001).
6.
Bazzigher L, Schwarz A, Staeheli P: No enhanced influenza virus resistance of murine and avian cells expressing cloned duck Mx protein. Virology 195:100–112 (1993).
7.
Beare AS, Webster RG: Replication of avian influenza viruses in humans. Arch Virol 119:37–42 (1991).
8.
Beaton AR, Krug RM: Transcription antitermination during influenza viral template RNA synthesis requires the nucleocapsid protein and the absence of a 5′ capped end. Proc Natl Acad Sci USA 83:6282–6286 (1986).
9.
Bernasconi D, Schultz U, Staeheli P: The interferon-induced Mx protein of chickens lacks antiviral activity. J Interferon Cytokine Res 15:47–53 (1995).
10.
Bulaga LL, Garber L, Senne DA, Myers TJ, Good R, et al: Epidemiologic and surveillance studies on avian influenza in live-bird markets in New York and New Jersey, 2001. Avian Dis 47:996–1001 (2003).
11.
Burgui I, Aragon T, Ortin J, Nieto A: PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes. J Gen Virol 84:3263–3274 (2003).
12.
Burt DW: Applications of biotechnology in the poultry industry. Worlds Poult Sci J 58:5–13 (2002).
13.
Burt DW: Chicken genome: current status and future opportunities. Genome Res 15:1692–1698 (2005).
14.
Campbell CH, Webster RG, Breese SS Jr: Fowl plague virus from man. J Infect Dis 122:513–516 (1970).
15.
Capua I, Marangon S: Vaccination policy applied for the control of avian influenza in Italy. Dev Biol (Basel) 114:213–219 (2003).
16.
Capua I, Marangon S: Vaccination for avian influenza in Asia. Vaccine 22:4137–4138 (2004).
17.
Capua I, Marangon S, Bonfanti L: Eradication of low pathogenicity avian influenza of the H7N3 subtype from Italy. Vet Rec 154:639–640 (2004).
18.
Crawford PC, Dubovi EJ, Castleman WL, Stephenson I, Gibbs EP, et al: Transmission of equine influenza virus to dogs. Science 310:482–485 (2005).
19.
Ellis TM, Bousfield RB, Bissett LA, Dyrting KC, Luk GS, et al: Investigation of outbreaks of highly pathogenic H5N1 avian influenza in waterfowl and wild birds in Hong Kong in late 2002. Avian Pathol 33:492–505 (2004).
20.
Falcon AM, Fortes P, Marion RM, Beloso A, Ortin J: Interaction of influenza virus NS1 protein and the human homologue of Staufen in vivo and in vitro. Nucleic Acids Res 27:2241–2247 (1999).
21.
Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, et al: Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA 101:1356–1361 (2004).
22.
Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, et al: Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79:2814–2822 (2005).
23.
Gambaryan A, Webster R, Matrosovich M: Differences between influenza virus receptors on target cells of duck and chicken. Arch Virol 147:1197–1208 (2002).
24.
Gilbert M, Chaitaweesub P, Parakamawongsa T, Premashthira S, Tiensin T, et al: Free-grazing ducks and highly pathogenic avian influenza, Thailand. Emerg Infect Dis 12:227–234 (2006).
25.
Gross G, Ikenberg H, Roussaki A, Drees N, Schopf E: Systemic treatment of condylomata acuminata with recombinant interferon-alpha-2a: low-dose superior to the high-dose regimen. Chemotherapy 32:537–541 (1986).
26.
Guo Y, Xu X, Wan X: (Genetic characterization of an avian influenza A (H5N1) virus isolated from a sick goose in China). Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 12:322–325 (1998).
27.
Haller O: Human MxA protein protects transgenic mice from infection with Thogoto virus. J Interferon Res 13:S121 (1993).
28.
Hatada E, Fukuda R: Binding of influenza A virus NS1 protein to dsRNA in vitro. J Gen Virol 73:3325–3329 (1992).
29.
Hatada E, Saito S, Fukuda R: Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J Virol 73:2425–2433 (1999).
30.
Hatta M, Kawaoka Y: The continued pandemic threat posed by avian influenza viruses in Hong Kong. Trends Microbiol 10:340–344 (2002).
31.
Helenius A: Unpacking the incoming influenza virus. Cell 69:577–578 (1992).
32.
Hinshaw VS, Bean WJ, Webster RG, Sriram G: Genetic reassortment of influenza A viruses in the intestinal tract of ducks. Virology 102:412–419 (1980a).
33.
Hinshaw VS, Webster RG, Bean WJ, Sriram G: The ecology of influenza viruses in ducks and analysis of influenza viruses with monoclonal antibodies. Comp Immunol Microbiol Infect Dis 3:155–164 (1980b).
34.
Holsinger LJ, Nichani D, Pinto LH, Lamb RA: Influenza A virus M2 ion channel protein: a structure-function analysis. J Virol 68:1551–1563 (1994).
35.
Horimoto T, Kawaoka Y: Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. J Virol 68:3120–3128 (1994).
36.
Horimoto T, Kawaoka Y: Biologic effects of introducing additional basic amino acid residues into the hemagglutinin cleavage site of a virulent avian influenza virus. Virus Res 50:35–40 (1997).
37.
Horisberger MA: Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins. J Virol 66:4705–4709 (1992).
38.
Horisberger MA: Interferons Mx genes and resistance to influenza virus. Am J Respir Crit Care Med 152:S67–S71 (1995).
39.
Huang TS, Palese P, Krystal M: Determination of influenza virus proteins required for genome replication. J Virol 64:5669–5673 (1990).
40.
Hulse-Post DJ, Sturm-Ramirez KM, Humberd J, Seiler P, Govorkova E, et al: Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci USA 102:10682–10687 (2005).
41.
Humberd J, Guan Y, Webster RG: Comparison of the replication of influenza A viruses in Chinese ring-necked pheasants and chukar partridges. J Virol 80:2151–2161 (2006).
42.
Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, et al: Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 72:7367–7373 (1998).
43.
Ito T, Goto H, Yamamoto E, Tanaka H, Takeuchi M, et al: Generation of a highly pathogenic avian influenza A virus from an avirulent field isolate by passaging in chickens. J Virol 75:4439–4443 (2001).
44.
Kawaoka Y, Webster RG: Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc Natl Acad Sci USA 85:324–328 (1988).
45.
Kawaoka Y, Naeve CW, Webster RG: Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? Virology 139:303–316 (1984).
46.
Kawaoka Y, Nestorowicz A, Alexander DJ, Webster RG: Molecular analyses of the hemagglutinin genes of H5 influenza viruses: origin of a virulent turkey strain. Virology 158:218–227 (1987).
47.
Kawaoka Y, Chambers TM, Sladen WL, Webster RG: Is the gene pool of influenza viruses in shorebirds and gulls different from that in wild ducks? Virology 163:247–250 (1988).
48.
Kawaoka Y, Krauss S, Webster RG: Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 63:4603–4608 (1989).
49.
Krug RM, Alonso-Caplen FV, Julkunen I, Katze MG: Expression and replication of the influenza virus genome, in Krug RM (ed): The Influenza Viruses, pp 89–152 (Plenum Press, New York 1989).
50.
Krug RM, Yuan W, Noah DL, Latham AG: Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. Virology 309:181–189 (2003).
51.
Kuiken T, Holmes EC, McCauley J, Rimmelzwaan GF, Williams CS, Grenfell BT: Host species barriers to influenza virus infections. Science 312:394–397 (2006).
52.
Lamb RA: Genes and proteins of the influenza viruses, in Krug RM (ed): The Influenza Viruses (Plenum Press, New York 1989).
53.
Lamb RA, Lai CJ: Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus. Cell 21:475–485 (1980).
54.
Lamb RA, Lai CJ: Expression of unspliced NS1 mRNA spliced NS2 mRNA and a spliced chimera mRNA from cloned influenza virus NS DNA in an SV40 vector. Virology 135:139–147 (1984).
55.
Lamb RA, Lai CJ, Choppin PW: Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci USA 78:4170–4174 (1981).
56.
Lee CW, Senne DA, Suarez DL: Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 78:8372–8381 (2004).
57.
Lee SH, Vidal SM: Functional diversity of Mx proteins: variations on a theme of host resistance to infection. Genome Res 12:527–530 (2002).
58.
Liu M, He S, Walker D, Zhou N, Perez DR, et al: The influenza virus gene pool in a poultry market in South central China. Virology 305:267–275 (2003).
59.
Lu Y, Wambach M, Katze MG, Krug RM: Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214:222–228 (1995).
60.
Makarova NV, Ozaki H, Kida H, Webster RG, Perez DR: Replication and transmission of influenza viruses in Japanese quail. Virology 310:8–15 (2003).
61.
Marangon S, Capua I: Control of avian influenza in Italy: from stamping out to emergency and prophylactic vaccination. Dev Biol (Basel) 124:109–115 (2006).
62.
Martin K, Helenius A: Transport of incoming influenza virus nucleocapsids into the nucleus. J Virol 65:232–244 (1991).
63.
Martin V, Sims L, Lubroth J, Pfeiffer D, Slingenbergh J, Domenech J: Epidemiology and ecology of highly pathogenic avian influenza with particular emphasis on South East Asia. Dev Biol (Basel) 124:23–36 (2006).
64.
Matrosovich M, Zhou N, Kawaoka Y, Webster R: The surface glycoproteins of H5 influenza viruses isolated from humans chickens and wild aquatic birds have distinguishable properties. J Virol 73:1146–1155 (1999).
65.
Meier E, Kunz G, Haller O, Arnheiter H: Activity of rat Mx proteins against a rhabdovirus. J Virol 64:6263–6269 (1990).
66.
Mullaney R: Live-bird market closure activities in the northeastern United States. Avian Dis 47:1096–1098 (2003).
67.
Muller M, Brenig B, Winnacker EL, Brem G: Transgenic pigs carrying cDNA copies encoding the murine Mx1 protein which confers resistance to influenza virus infection. Gene 121:263–270 (1992).
68.
Munster VJ, Wallensten A, Baas C, Rimmelzwaan GF, Schutten M, et al: Mallards and highly pathogenic avian influenza ancestral viruses, northern Europe. Emerg Infect Dis 11:1545–1551 (2005).
69.
Nakayama M, Nagata K, Kato A, Ishihama A: Interferon-inducible mouse Mx1 protein that confers resistance to influenza virus is GTPase. J Biol Chem 266:21404–21408 (1991).
70.
Nakayama M, Nagata K, Ishihama A: Enzymatic properties of the mouse Mx1 protein-associated GTPase. Virus Res 22:227–234 (1992).
71.
Nemeroff ME, Qian XY, Krug RM: The influenza virus NS1 protein forms multimers in vitro and in vivo. Virology 212:422–428 (1995).
72.
Nguyen DC, Uyeki TM, Jadhao S, Maines T, Shaw M, et al: Isolation and characterization of avian influenza viruses including highly pathogenic H5N1 from poultry in live bird markets in Hanoi, Vietnam in 2001. J Virol 79:4201–4212 (2005).
73.
Notter DR: The importance of genetic diversity in livestock populations of the future. J Anim Sci 77:61–69 (1999).
74.
Palese P, Ritchey MB, Schulman JL: Mapping of the influenza virus genome II. Identification of the P1, P2 and P3 genes. Virology 76:114–121 (1977).
75.
Pavlovic J, Zurcher T, Haller O, Staeheli P: Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J Virol 64:3370–3375 (1990).
76.
Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, et al: Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363:617–619 (2004).
77.
Perez DR, Lim W, Seiler JP, Yi G, Peiris M, et al: Role of quail in the interspecies transmission of H9 influenza A viruses: molecular changes on HA that correspond to adaptation from ducks to chickens. J Virol 77:3148–3156 (2003a).
78.
Perez DR, Webby RJ, Hoffmann E, Webster RG: Land-based birds as potential disseminators of avian mammalian reassortant influenza A viruses. Avian Dis 47:1114–1117 (2003b).
79.
Perez DR, Sorrell EM, Donis RO: Avian influenza: an omnipresent pandemic threat. Pediatr Infect Dis J 24:S208–216, discussion S215 (2005).
80.
Perkins LE, Swayne DE: Pathobiology of A/chicken/Hong Kong/220/97 (H5N1) avian influenza virus in seven gallinaceous species. Vet Pathol 38:149–164 (2001).
81.
Perkins LE, Swayne DE: Pathogenicity of a Hong Kong-origin H5N1 highly pathogenic avian influenza virus for emus, geese, ducks and pigeons. Avian Dis 46:53–63 (2002a).
82.
Perkins LE, Swayne DE: Susceptibility of laughing gulls (Larus atricilla) to H5N1 and H5N3 highly pathogenic avian influenza viruses. Avian Dis 46:877–885 (2002b).
83.
Perkins LE, Swayne DE: Varied pathogenicity of a Hong Kong-origin H5N1 avian influenza virus in four passerine species and budgerigars. Vet Pathol 40:14–24 (2003).
84.
Pinto LH, Holsinger LJ, Lamb RA: Influenza virus M2 protein has ion channel activity. Cell 69:517–528 (1992).
85.
Pitossi F, Blank A, Schroder A, Schwarz A, Hussi P, et al: A functional GTP-binding motif is necessary for antiviral activity of Mx proteins. J Virol 67:6726–6732 (1993).
86.
Plotch SJ, Bouloy M, Ulmanen I, Krug RM: A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell 23:847–858 (1981).
87.
Qian XY, Chien CY, Lu Y, Montelione GT, Krug RM: An amino-terminal polypeptide fragment of the influenza virus NS1 protein possesses specific RNA-binding activity and largely helical backbone structure. RNA 1:948–956 (1995).
88.
Reid AH, Fanning TG, Hultin JV, Taubenberger JK: Origin and evolution of the 1918 ‘Spanish’ influenza virus hemagglutinin gene. Proc Natl Acad Sci USA 96:1651–1656 (1999).
89.
Reid AH, Fanning TG, Janczewski TA, Taubenberger JK: Characterization of the 1918 ‘Spanish’ influenza virus neuraminidase gene. Proc Natl Acad Sci USA 97:6785–6790 (2000).
90.
Romanov MN: Poultry genetic resources in the countries of Eastern Europe – history and current state. Poult Avian Biol Rev 7:1–29 (1996).
91.
Romanov MN, Weigend S: Analysis of genetic relationships between various populations of domestic and jungle fowl using microsatellite markers. Poult Sci 80:1057–1063 (2001).
92.
Rott R, Klenk HD, Nagai Y, Tashiro M: Influenza viruses, cell enzymes and pathogenicity. Am J Respir Crit Care Med 152:S16–S19 (1995).
93.
Samuel CE: Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183:1–11 (1991).
94.
Schnorr JJ, Schneider-Schaulies S, Simon-Jodicke A, Pavlovic J, Horisberger MA, ter Meulen V: MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J Virol 67:4760–4768 (1993).
95.
Scholtissek C: Source for influenza pandemics. Eur J Epidemiol 10:455–458 (1994).
96.
Scholtissek C: Molecular evolution of influenza viruses. Virus Genes 11:209–215 (1995).
97.
Scholtissek C: Molecular epidemiology of influenza. Arch Virol Suppl 13:99–103 (1997).
98.
Scholtissek C, Rohde W, Von Hoyningen V, Rott R: On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 87:13–20 (1978).
99.
Senne DA, Suarez DL, Stallnecht DE, Pedersen JC, Panigrahy B: Ecology and epidemiology of avian influenza in North and South America. Dev Biol (Basel) 124:37–44 (2006).
100.
Shortridge KF: Pandemic influenza: a zoonosis? Semin Respir Infect 7:11–25 (1992).
101.
Skehel JJ, Wiley DC: Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531–569 (2000).
102.
Slemons RD, Condobery PK, Swayne DE: Assessing pathogenicity potential of waterfowl-origin type A influenza viruses in chickens. Avian Dis 35:210–215 (1991).
103.
Staeheli P: Interferon-induced proteins and the antiviral state. Adv Virus Res 38:147–200 (1990).
104.
Staeheli P, Haller O, Boll W, Lindenmann J, Weissmann C: Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44:147–158 (1986).
105.
Stallknecht DE, Shane SM: Host range of avian influenza virus in free-living birds. Vet Res Commun 12:125–141 (1988).
106.
Steinhauer DA: Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258:1–20 (1999).
107.
Suarez DL, Schultz-Cherry S: Immunology of avian influenza virus: a review. Dev Comp Immunol 24:269–283 (2000).
108.
Swayne DE, Halvorson DA: Influenza, in Saif YM (ed): Diseases of Poultry, pp 135–160 (Iowa State Press, Blackwell Publishing Co, Ames 2003).
109.
Swayne DE, Suarez DL: Highly pathogenic avian influenza. Rev Sci Tech 19:463–482 (2000).
110.
Tan SL, Katze MG: Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. J Interferon Cytokine Res 18:757–766 (1998).
111.
Taubenberger JK, Reid AH, Krafft AE, Bijwaard KE, Fanning TG: Initial genetic characterization of the 1918 ‘Spanish’ influenza virus. Science 275:1793–1796 (1997).
112.
Tompkins SM, Lo CY, Tumpey TM, Epstein SL: Protection against lethal influenza virus challenge by RNA interference in vivo. Proc Natl Acad Sci USA 101:8682–8686 (2004).
113.
Tumpey TM, Suarez DL, Perkins LE, Senne DA, Lee JG, et al: Characterization of a highly pathogenic H5N1 avian influenza A virus isolated from duck meat. J Virol 76:6344–6355 (2002).
114.
Tweed SA, Skowronski DM, David ST, Larder A, Petric M, et al: Human illness from avian influenza H7N3 British Columbia. Emerg Infect Dis 10:2196–2199 (2004).
115.
Ulmanen I, Broni B, Krug RM: Influenza virus temperature-sensitive cap (m7GpppNm)-dependent endonuclease. J Virol 45:27–35 (1983).
116.
Veits J, Wiesner D, Fuchs W, Hoffmann B, Granzow H, et al: Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci USA 103:8197–8202 (2006).
117.
von Grotthuss M, Rychlewski L: Influenza mutation from equine to canine. Science 311:1241–1242; author reply 1241–1242 (2006).
118.
Walker JA, Kawaoka Y: Importance of conserved amino acids at the cleavage site of the haemagglutinin of a virulent avian influenza A virus. J Gen Virol 74:311–314 (1993).
119.
Wan H, Perez DR: Quail carry sialic acid receptors compatible with binding of avian and human influenza viruses. Virology 346:278–286 (2006).
120.
Webster RG: Influenza virus: transmission between species and relevance to emergence of the next human pandemic. Arch Virol Suppl 13:105–113 (1997).
121.
Webster R, Hulse D: Controlling avian flu at the source. Nature 435:415–416 (2005).
122.
Webster RG, Yakhno M, Hinshaw VS, Bean WJ, Murti KG: Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology 84:268–278 (1978).
123.
Webster RG, Bean W, Gorman OT, Chambers TM, Kawaoka Y: Evolution and ecology of influenza A viruses. Microbiol Rev 56:152–179 (1992).
124.
Webster RG, Guan Y, Peiris M, Walker D, Krauss S, et al: Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China. J Virol 76:118–126 (2002).
125.
Wolff T, O’Neill RE, Palese P: Interaction cloning of NS1-I, a human protein that binds to the nonstructural NS1 proteins of influenza A and B viruses. J Virol 70:5363–5372 (1996).
126.
Wolff T, O’Neill RE, Palese P: NS1-Binding protein (NS1-BP): a novel human protein that interacts with the influenza A virus nonstructural NS1 protein is relocalized in the nuclei of infected cells. J Virol 72:7170–7180 (1998).
127.
Wood JM, Major D, Newman RW, Dunleavy U, Nicolson C, et al: Preparation of vaccines against H5N1 influenza. Vaccine 20(suppl 2):S84–S87 (2002).
128.
Yoon KJ, Cooper VL, Schwartz KJ, Harmon KM, Kim WI, et al: Influenza virus infection in racing greyhounds. Emerg Infect Dis 11:1974–1976 (2005).
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.